The Trump administration has begun layoffs at the Food and Drug Administration (FDA), particularly affecting probationary employees responsible for reviewing the safety of food, medical devices, and tobacco products. The overall number of positions eliminated remains unclear, but reports suggest a large cut of 5,200 positions across the Department of Health and Human Services (HHS), including the FDA and CDC. Despite these layoffs, crucial health programs and positions within the CDC are reportedly unaffected. The FDA has faced ongoing scrutiny from Health Secretary Robert Kennedy Jr., who previously criticized the agency's decisions on alternative therapies.
The Trump administration's effort to slash the size of the federal workforce led to significant layoffs at the FDA, impacting the agency's ability to ensure public health.
Probationary employees across the FDA received notices that their positions were eliminated, primarily affecting those in food and medical device oversight.
Reports indicated that the U.S. Department of Health and Human Services could fire up to 5,200 probationary employees across its agencies, including the FDA and CDC.
Health Secretary Robert Kennedy Jr. has been critical of the FDA, accusing it of not approving certain alternative therapies and suggesting a 'war on public health'.
Collection
[
|
...
]